Major Lung Cancer Advance: Yale Researchers Link Genetic Marker to Deadly Disease Onset

Oct. 16–Yale scientists have discovered a novel way to assess the risk of lung cancer in moderate smokers, promising new methods to diagnose, and possibly someday treat, the intractable disease, and other forms of cancer. The research, published in the Wednesday edition of the journal Cancer Research, identified a biological marker for lung cancer. “Only 10 percent of smokers will develop lung cancer in their lifetime, and genetic testing to determine the population of smokers who are most predisposed to develop the disease is needed to help guide better evaluation for these people,” said Dr. Joanne B. Weidhaas, assistant professor of therapeutic radiation at the Yale School of Medicine, and one of the study’s authors. By Abram Katz, New Haven Register, Conn.

To see more of New Haven Register, or to subscribe to the newspaper, go to http://www.nhregister.com.

Copyright (c) 2008, New Haven Register, Conn.

Distributed by McClatchy-Tribune Information Services.

For reprints, email tmsreprints@permissionsgroup.com, call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

A service of YellowBrix, Inc.